Shares of Hims & Hers Health Inc. (HIMS) tumbled 5.03% in pre-market trading on Wednesday, following the company's first-quarter earnings report and subsequent guidance update. The health and wellness company's stock movement comes as a surprise, given its impressive 18.1% surge in the previous trading session.
Hims & Hers Health reported first-quarter earnings that topped Wall Street estimates, showcasing the company's strong performance in the near term. However, investors seem to be focusing on the company's long-term outlook, which fell short of expectations. For the second quarter, Hims & Hers expects revenue between $530 million to $550 million, significantly below analysts' expectations of $564.6 million.
This pre-market plunge highlights the market's sensitivity to forward-looking guidance, especially for growth-oriented companies in the health and wellness sector. Despite the company's ability to beat current quarter estimates, the lower long-term sales projection has sparked concerns among investors about the company's future growth trajectory. As the market digests this information, it remains to be seen how Hims & Hers Health will navigate these expectations and maintain investor confidence in the coming quarters.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.